StemCells Inc is one of the few companies that has actually entered clinical trials. In this patent the extraction of specific neuronal stem cells is disclosed. Cells that bind to the antibodies 5E12 and/or AC133 derived from brain sources are identified as neuronal stem cells capable of inducing production of neurospheres. These cells have also demonstrated ability to integrate into the brains of immunodeficient mice.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.